Defence Therapeutics's total assets for Q1 2026 were C$2.77M, an increase of 67.63% from the previous quarter. TSE:DTC total liabilities were C$4.18M for the fiscal quarter, a 43.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.